A faulty electronic component in some Philips HeartStart automated external defibrillators may prevent the device from delivering a needed shock to a person suffering a cardiac emergency, the FDA ...
The North American subsidiary of Amsterdam-based Royal Philips reached an agreement on a consent decree with the U.S. Department of Justice, representing the Food and Drug Administration, the company ...
Amsterdam, the Netherlands and Cambridge, MA – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that the Center for Devices and Radiological Health (CDRH) of ...
LONDON — Koninklijke Philips Electronics NV (Amsterdam, The Netherlands), a leading vendor of consumer and medical products, has announced that it is recalling approximately 5,400 HeartStart FR2+ ...
Certain HeartStart automated external defibrillator devices made by Philips Medical Systems might be unable to deliver needed defibrillator shocks in a cardiac emergency, the Food and Drug ...
Philips recalled its HeartStart MRx Defibrillator due to an equipment defect, according to a Feb. 9 safety notice from the FDA. Here are three things to know. 1. Philips initiated the recall in June ...
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced today that its Emergency Care and Resuscitation (ECR) business is resuming ...
Philips receives FDA premarket approval for its HeartStart OnSite and HeartStart Home defibrillators
Amsterdam, the Netherlands –Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that the Center for Devices and Radiological Health (CDRH) of the Food and Drug ...
Washington(CBS.MW) -- The Food and Drug Administration Thursday granted market clearance to Philips Medical Systems' HeartStart Home Defibrillator for use without a prescription. The action marks the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results